Skip to main content
. 2015 Jan 9;17(1):2. doi: 10.1186/s13058-014-0507-6

Figure 2.

Figure 2

Kaplan-Meier estimates of probabilities of progression-free survival, according to baseline circulating tumor cell count in patients with newly diagnosed inflammatory breast cancer.